Dasari A, Lonardi S, Garcia-Carbonero R, Elez E, et al. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study. Lancet 2023 Jun 15:S0140-6736(23)00772-9. doi: 10.1016/S0140-6736(23)00772.
PMID: 37331369